1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow TearSolutions, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome 0.005% Lacripep, 0.01% Lacripep, Placebo - Primary Sjögren Syndrome, Dry Eye | Phase 1 / Phase 2 | Completed | TearSolutions, Inc. | 204 | 2017-06-30 | 2020-01-22 |
Dry Eye Syndromes (1) · Sjogren's Syndrome (1)
United States (1)
Marc Odrich, MD (1)